Literature DB >> 19246097

Deficiency of the complement regulator CD59a exacerbates Wallerian degeneration.

Valeria Ramaglia1, Rosalind Helen Mary King, Bryan Paul Morgan, Frank Baas.   

Abstract

The complement system is implicated in Wallerian degeneration (WD). We have previously shown that the membrane attack complex (MAC), the terminal activation product of the complement cascade, mediates rapid axonal degradation and myelin clearance during WD after peripheral nerve injury. In this study we analyzed the contribution of CD59a, a cell membrane negative regulator of the MAC, to WD. Following injury, the level of MAC deposition was higher in the CD59a deficient mice than wildtypes whereas the residual axonal content was lower in CD59a deficient mice than wildtypes, strongly implicating MAC as a determinant of axonal damage during WD. The number of endoneurial macrophages was significantly higher in CD59a deficient mice compared to wildtypes at 1 day post-injury. These findings are relevant to the understanding of the mechanisms of axon loss in injury and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246097     DOI: 10.1016/j.molimm.2009.01.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  C3-dependent mechanism of microglial priming relevant to multiple sclerosis.

Authors:  Valeria Ramaglia; Timothy R Hughes; Rossen M Donev; Marieta M Ruseva; Xiaobo Wu; Inge Huitinga; Frank Baas; James W Neal; B Paul Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

Review 2.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

3.  The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

Authors:  Fei Qiao; Carl Atkinson; Mark S Kindy; Anandakumar Shunmugavel; B Paul Morgan; Hongbin Song; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

Review 4.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

5.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

6.  The alternative complement pathway regulates pathological angiogenesis in the retina.

Authors:  J Harry Sweigard; Ryoji Yanai; Philipp Gaissert; Magali Saint-Geniez; Keiko Kataoka; Aristomenis Thanos; Gregory L Stahl; John D Lambris; Kip M Connor
Journal:  FASEB J       Date:  2014-03-25       Impact factor: 5.191

7.  M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator.

Authors:  Nawal Bahia El Idrissi; Pranab K Das; Kees Fluiter; Patricia S Rosa; Jeroen Vreijling; Dirk Troost; B Paul Morgan; Frank Baas; Valeria Ramaglia
Journal:  Acta Neuropathol       Date:  2015-03-15       Impact factor: 17.088

8.  Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice.

Authors:  Gareth R Howell; Ileana Soto; Margaret Ryan; Leah C Graham; Richard S Smith; Simon W M John
Journal:  J Neuroinflammation       Date:  2013-06-27       Impact factor: 8.322

9.  In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.

Authors:  Nawal Bahia El Idrissi; Anand M Iyer; Valeria Ramaglia; Patricia S Rosa; Cleverson T Soares; Frank Baas; Pranab K Das
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

10.  Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.

Authors:  Iliana Michailidou; Aldo Jongejan; Jeroen P Vreijling; Theodosia Georgakopoulou; Marit B de Wissel; Ruud A Wolterman; Patrick Ruizendaal; Ngaisah Klar-Mohamad; Anita E Grootemaat; Daisy I Picavet; Vinod Kumar; Cees van Kooten; Trent M Woodruff; B Paul Morgan; Nicole N van der Wel; Valeria Ramaglia; Kees Fluiter; Frank Baas
Journal:  Acta Neuropathol Commun       Date:  2018-05-03       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.